HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 0.16
Day range
kr 0.16 - kr 0.17
Year range
kr 0.16 - kr 0.75
Market cap
111.56M SEK
Avg Volume
6.78M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 354.00K | -22.20% |
Operating expense | 16.63M | -45.70% |
Net income | -17.33M | -664.40% |
Net profit margin | -4.89K | -825.42% |
Earnings per share | -0.03 | — |
EBITDA | -15.70M | 45.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.46M | 205.94% |
Total assets | 88.21M | 166.97% |
Total liabilities | 23.48M | 9.74% |
Total equity | 64.74M | — |
Shares outstanding | 672.67M | — |
Price to book | 1.60 | — |
Return on assets | -65.05% | — |
Return on capital | -105.38% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.33M | -664.40% |
Cash from operations | -19.78M | 30.04% |
Cash from investing | — | — |
Cash from financing | 70.79M | 6,880.75% |
Net change in cash | 50.89M | 276.18% |
Free cash flow | -13.89M | -5.35% |
About
Founded
2007
Website
Employees
13
